- Approval Id
- 27973d331e28b4f4
- Drug Name
- HERBESSER 90 SR CAPSULE 90 mg
- Product Name
- HERBESSER 90 SR CAPSULE 90 mg
- Approval Number
- SIN06791P
- Approval Date
- 1991-12-20
- Registrant
- MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.
- Licence Holder
- MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- CAPSULE
- Dosage
- **(DOSAGE AND ADMINISTRATION)**
For adults, 1 capsule (90 mg as diltiazem hydrochloride) twice a day orally. The dosage may be increased or decreased according to the severity of symptoms. Diltiazem hydrochloride has an additive antihypertensive effect when used with other antihypertensive agents. Therefore, the dosage of diltiazem hydrochloride or the concomitant antihypertensives may need to be adjusted when adding one to the other.
- Route Of Administration
- ORAL
- Indication Info
- **(INDICATION)**
- Hypertension. It may be used alone or in combination with other antihypertensive medications, such as diuretics.
- Angina pectoris, Variant angina.
- Contraindications
- Under **(PRECAUTIONS)**
1. HERBESSER 90 SR is contraindicated to the following patients:
1. Patients having atrioventricular block 2nd and 3rd degree or sinoatrial block.
2. Pregnant women and women of pregnant suspicion.
3. Patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker.
4. Patients with hypotension (less than 90 mmHg systolic).
5. Patients who have demonstrated hypersensitivity to the drug.
6. Patients with acute myocardial infarction and pulmonary congestion documented by X-ray on admission.
7. Patients receiving ivabradine hydrochloride.
- Atc Code
- C08DB01
- Atc Item Name
- diltiazem
- Pharma Manufacturer Name
- MITSUBISHI TANABE PHARMA SINGAPORE PTE. LTD.
- Company Detail Path
- /organization/mitsubishi-tanabe-pharma-singapore-pte-ltd
